Full text is available at the source.
Abstract
Nearly 25% of patients in the US Department of Veterans Affairs health care system have type 2 diabetes mellitus.
- Semaglutide 2 mg may significantly improve hemoglobin A1c levels compared to semaglutide 1 mg in non-insulin users.
- The study investigates the impact of increasing semaglutide dosage on total daily insulin requirements.
- Effects on insulin dosage are not yet reported or concluded.
Simplified